The Justice Department Will Appeal AT&T-Time Warner Deal
*By Alisha Haridasani*
The Justice Department will appeal the $85 billion AT&T-Time Warner mega-merger a month after a federal judge gave it his blessing.
That's according to court papers reportedly filed on Thursday, which challenge Judge Richard Leon's ruling that the government did not sufficiently prove a deal would hurt competition in the industry.
At the time, Leon also tried to dissuade the DoJ from filing an appeal.
“A stay pending appeal would be a manifestly unjust outcome in this case,” wrote Judge Richard Leon. “I do not believe that the government has a likelihood of success on the merits of an appeal.”
Since receiving the green light, AT&T completed its acquisition of Time Warner and created a new company called WarnerMedia, which started offering skinny bundles for consumers leveraging on content from CNN, TBS, and TNT.
But while the companies promised the deal would not raise prices for consumers, AT&T earlier this month hiked the monthly rate for most of its DirecTV Now video streaming plans. Amazon Studios' former head of strategy Matthew Ball [pointed out](https://twitter.com/ballmatthew/status/1017507315266785280) that may have been a bad move.
AT&T shares fell by more than 1 percent on the news in after hours trading.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
